ATP citrate lyase drives vascular remodeling in systemic and pulmonary vascular diseases through metabolic and epigenetic changesYann Grobs, Sébastien Bonnet, Charlotte Romanet et al.|Science Translational Medicine|2024Cited by 33
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical StudiesSarah‐Eve Lemay, Sébastien Bonnet, Sandra Breuils‐Bonnet et al.|Circulation|2025Cited by 26
Unraveling AURKB as a potential therapeutic target in pulmonary hypertension using integrated transcriptomic analysis and pre-clinical studiesSarah‐Eve Lemay, Olivier Boucherat, Manon Mougin et al.|Cell Reports Medicine|2025Cited by 8
Integrin α5β1: a promising target for right ventricular dysfunction in pulmonary arterial hypertensionSarah‐Eve Lemay, Sébastien Bonnet, Yann Grobs et al.|Unknown|2025Cited by 1
ATP Citrate Lyase Drives Vascular Remodeling Diseases Development Through Metabolic-Epigenetic ReprogramingYann Grobs, Sébastien Bonnet, Charlotte Romanet et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 1